321 related articles for article (PubMed ID: 32346744)
21. Guidelines of care for the management of cutaneous squamous cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.
Bailly-Caillé B; Levard R; Kottler D; Dompmartin A; L'Orphelin JM
Cancer Immunol Immunother; 2024 May; 73(7):118. PubMed ID: 38713217
[TBL] [Abstract][Full Text] [Related]
23. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
[TBL] [Abstract][Full Text] [Related]
24. High-risk cutaneous squamous cell carcinoma.
Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
[TBL] [Abstract][Full Text] [Related]
25. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
26. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
27. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
[TBL] [Abstract][Full Text] [Related]
28. Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report.
Manyam BV; Nwizu TI; Rahe ML; Harr BA; Koyfman SA
Anticancer Res; 2015 Oct; 35(10):5511-4. PubMed ID: 26408717
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
30. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
31. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel.
Lebas E; Marchal N; Rorive A; Nikkels AF
Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680
[TBL] [Abstract][Full Text] [Related]
32. Management of High-Risk Squamous Cell Carcinoma of the Skin.
Fu T; Aasi SZ; Hollmig ST
Curr Treat Options Oncol; 2016 Jul; 17(7):34. PubMed ID: 27262708
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
Bucknell NW; Gyorki DE; Bressel M; Estall V; Webb A; Henderson M; Chua MS; Rischin D; Tiong A
Australas J Dermatol; 2022 Feb; 63(1):43-52. PubMed ID: 34751431
[TBL] [Abstract][Full Text] [Related]
34. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
35. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
36. [Covering of parotid and cervical lymph nodes metastasis of cutaneous squamous cell carcinoma of the head, about 18 cases].
Vatin L; Morvan JB; Rivière D; Okremchouk I; Abed S; Verdalle P
Rev Laryngol Otol Rhinol (Bord); 2015; 136(1):9-15. PubMed ID: 26749599
[TBL] [Abstract][Full Text] [Related]
37. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
[TBL] [Abstract][Full Text] [Related]
38. Update of advanced cutaneous squamous cell carcinoma.
de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.
Horenblas S; van Tinteren H; Delemarre JF; Moonen LM; Lustig V; van Waardenburg EW
J Urol; 1993 Mar; 149(3):492-7. PubMed ID: 8437253
[TBL] [Abstract][Full Text] [Related]
40. Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck.
Varra V; Smile TD; Geiger JL; Koyfman SA
Curr Treat Options Oncol; 2020 Apr; 21(5):37. PubMed ID: 32328817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
